Skip to Content
MilliporeSigma
All Photos(1)

Documents

11569

Supelco

3,4-Dihydroxyphenylacetic acid

analytical standard

Synonym(s):

DOPAC, Homoprotocatechuic acid

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
(HO)2C6H3CH2CO2H
CAS Number:
102-32-9
Molecular Weight:
168.15
Beilstein/REAXYS Number:
2211017
EC Number:
203-024-1
MDL number:
MFCD00004338
UNSPSC Code:
77101502
PubChem Substance ID:
329749488
NACRES:
NA.24

grade

analytical standard

Quality Level

100

assay

≥97.0% (HPLC)
97.0-103.0% (T)

shelf life

limited shelf life, expiry date on the label

technique(s)

HPLC: suitable
gas chromatography (GC): suitable

mp

127-130 °C (lit.)

application(s)

pharmaceutical

format

neat

SMILES string

OC(=O)Cc1ccc(O)c(O)c1

InChI

1S/C8H8O4/c9-6-2-1-5(3-7(6)10)4-8(11)12/h1-3,9-10H,4H2,(H,11,12)

InChI key

CFFZDZCDUFSOFZ-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

3,4-Dihydroxyphenylacetic acid may be used as a reference standard for the determination of 3,4-dihydroxyphenylacetic acid in rat samples by high-performance liquid chromatography with electrochemical detection.
Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

Other Notes

2024 CiteAb Award Winner for Supplier Succeeding in Parkinson′s Research

pictograms

Exclamation mark
GHS07

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 8

1 of 8

3-Methoxytyramine hydrochloride analytical standard

Supelco

75024

3-Methoxytyramine hydrochloride

3,4-Dihydroxyhydrocinnamic acid 98%

Sigma-Aldrich

102601

3,4-Dihydroxyhydrocinnamic acid

5-Hydroxyindole-3-acetic acid analytical standard

Supelco

55697

5-Hydroxyindole-3-acetic acid

Serotonin analytical standard

Supelco

14927

Serotonin

DL-3,4-Dihydroxyphenyl glycol

Sigma-Aldrich

D9753

DL-3,4-Dihydroxyphenyl glycol

Dopamine-1,1,2,2-d4 hydrochloride analytical standard

Supelco

73483

Dopamine-1,1,2,2-d4 hydrochloride

Dopamine hydrochloride

Sigma-Aldrich

H8502

Dopamine hydrochloride

Dopamine hydrochloride solution 1.0 mg/mL in methanol with 5% 1 M HCl (as free base), ampule of 1 mL, certified reference material, Cerilliant®

Supelco

D-081

Dopamine hydrochloride solution

Simultaneous determination of 3, 4?dihydroxyphenylalanine, 5?hydroxytryptophan, dopamine, 4?hydroxy?3?methoxyphenylalanine, norepinephrine, 3, 4?dihydroxyphenylacetic acid, homovanillic acid, serotonin, and 5?hydroxyindoleacetic acid in rat cerebrospinal fluid and brain by high?performance liquid chromatography with electrochemical detection.
Wagner J, et al.
Journal of Neurochemistry, 38(5), 1241-1254 (1982)
Jinhee Kim et al.
Biomolecules & therapeutics, 28(3), 282-291 (2020-04-28)
Inhaled solvents such as toluene are of particular concern due to their abuse potential that is easily exposed to the environment. The inhalation of toluene causes various behavioral problems, but, the effect of short-term exposure of toluene on changes in
Wanqiu Huang et al.
Journal of neurochemistry, 150(3), 282-295 (2019-05-24)
Neuroinflammation is one of the driving forces of progressive neurodegeneration in Parkinson's disease (PD). The metabolomics approach has been proved highly useful in identifying potential therapeutic targets. Here, to identify inflammation-relevant treatment targets for PD, mass spectrometry-based untargeted metabolomics was
Sandy Stayte et al.
PloS one, 10(4), e0124325-e0124325 (2015-04-23)
Parkinson's disease (PD) is a chronic neurodegenerative disease characterized by a significant loss of dopaminergic neurons within the substantia nigra pars compacta (SNpc) and a subsequent loss of dopamine (DA) within the striatum. Despite advances in the development of pharmacological
Bing Han et al.
Parkinsonism & related disorders, 20(11), 1191-1195 (2014-09-16)
Parkinson's disease (PD) is a progressive neurodegenerative movement disorder that is caused predominantly by the degeneration of the nigrostriatal dopaminergic pathway. Lateral habenula (LHb) has efferent projections that terminate in the substantia nigra pars compacta (SNpc) and electrical stimulation of
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service